Jackman Katherine A, Miller Alyson A, Drummond Grant R, Sobey Christopher G
Department of Pharmacology, Monash University, Clayton, Melbourne, Victoria 3800, Australia.
Brain Res. 2009 Aug 25;1286:215-20. doi: 10.1016/j.brainres.2009.06.056. Epub 2009 Jun 25.
Angiotensin II (Ang II) receptor blockade is beneficial in stroke, possibly due to attenuation of vascular oxidative stress. Mice genetically targeted for the superoxide-forming vascular NADPH oxidase subunit, NOX1, have a blunted hypertensive response to Ang II. We therefore hypothesised that NOX1 is mechanistically involved in Ang II-induced superoxide production by cerebral arteries, and potentially in stroke outcome. Superoxide production by cerebral arteries and brains from wild-type (WT) and NOX1 deficient (NOX1-KO) mice was measured using L-012-enhanced chemiluminescence. Ischemic stroke was induced by middle cerebral artery occlusion (MCAO; 0.5 h). Cerebral blood flow was measured using transcranial laser-Doppler flowmetry. After 24 h, neurological assessment was performed, mice were euthanised, and infarct and edema volumes were calculated. Basal superoxide was similar between WT and NOX1-KO in brain and cerebral artery homogenates, and in intact cerebral arteries. However, Ang II-stimulated increases in superoxide were approximately 70% smaller in rings from NOX1-KO versus WT. During MCAO, rCBF decreased by approximately 75% in both WT and NOX1-KO, and increased to similar levels in each strain immediately following reperfusion. No difference in neurological score, total or subcortical cerebral infarct volume or edema volume was observed between WT and NOX1-KO mice. However, cortical infarct volume (which was very modest in WT) was approximately 4-fold greater in brains of NOX1-KO versus WT. Thus, NOX1 is essential for superoxide production in large cerebral arteries in response to Ang II but not under basal conditions. Furthermore, NOX1 does not appear to contribute to stroke size, and it may limit cortical infarct development following cerebral ischemia.
血管紧张素II(Ang II)受体阻断对中风有益,这可能是由于血管氧化应激的减轻。基因靶向超氧化物形成血管NADPH氧化酶亚基NOX1的小鼠对Ang II的高血压反应减弱。因此,我们推测NOX1在机制上参与了Ang II诱导的脑动脉超氧化物生成,并可能与中风结局有关。使用L-012增强化学发光法测量野生型(WT)和NOX1缺陷型(NOX1-KO)小鼠脑动脉和大脑中的超氧化物生成。通过大脑中动脉闭塞(MCAO;0.5小时)诱导缺血性中风。使用经颅激光多普勒血流仪测量脑血流量。24小时后,进行神经学评估,对小鼠实施安乐死,并计算梗死体积和水肿体积。在脑和脑动脉匀浆以及完整脑动脉中,WT和NOX1-KO的基础超氧化物水平相似。然而,与WT相比,NOX1-KO环中Ang II刺激的超氧化物增加约小70%。在MCAO期间,WT和NOX1-KO的rCBF均下降约75%,再灌注后各品系均增加到相似水平。WT和NOX1-KO小鼠之间在神经学评分、总脑梗死体积或皮质下脑梗死体积或水肿体积方面未观察到差异。然而,NOX1-KO小鼠大脑中的皮质梗死体积(在WT中非常小)比WT大约4倍。因此,NOX1对于脑大动脉对Ang II反应时的超氧化物生成至关重要,但在基础条件下并非如此。此外,NOX1似乎对中风大小没有影响,并且它可能会限制脑缺血后皮质梗死的发展。